Omega-3 status test for prematurity risk

Omega-3 status test for prematurity risk
Project Status: In progress
Project administered by: The University of Adelaide

SA Pathology and SAHMRI are partnering to offer omega-3 testing for women with singleton pregnancies as part of the South Australian Maternal Serum Antenatal Screening (SAMSAS) program.

This will identify women who will benefit from omega-3 supplementation and appropriate advice to reduce their risk of early birth.

Updated National Health and Medical Research Council National Pregnancy Care guidelines recommend assessing omega-3 fatty acid status and supplementing pregnant women with low omega-3 intakes. The SA Pathology-SAHMRI collaboration will evaluate the feasibility and reach of the omega-3 screening.

Information for health professionals

Women with a singleton pregnancy and low omega-3 status (concentration) in their blood are at higher risk of early preterm birth than women with adequate omega-3 status. Supplementing women who are low in omega-3 reduces their risk of early birth. Screening before 20 weeks’ gestation will identify women who require omega-3 supplementation.

Omega-3 blood sample and cost

No additional blood sample is required as omega-3 analysis will be performed on serum collected as a part of the established SAMSAS program. The omega-3 fatty acid analyses will be performed at no cost to the patient or health service.

How to order the omega-3 status test?

  1. Discuss the omega-3 status test and refer woman to the Information for Families sheet.
  2. Order using the updated SAMSAS request form.
  3. Tick the omega-3 status test on the SAMSAS request form.
  4. Refer woman to the Privacy Disclosure on the SAMSAS request form.
  5. The omega-3 status test results will be reported to the requesting provider and will be available on OACIS.

For more information please download - Information for Health Professionals: Omega-3 status test for prematurity risk

brochure for professionals
Information for requesting providers
Information for health professionals
Evidence background
Information for families

Information for Families

Omega-3 fats are nutrients commonly found in fish and algae. Enough omega-3 in your body during pregnancy can help you have a full-term pregnancy. Babies born too soon (premature), particularly those born before 34 weeks of pregnancy, may have lengthy stays in hospital and may experience long-term health problems and delays in development.

Why omega-3 screening?

Women expecting one baby who have low omega-3 levels in their blood are at higher risk of having their baby born prematurely. They are most likely to benefit from omega-3 supplements. Women who have sufficient omega-3 levels are already at lower risk of having a premature baby and do not need to take additional omega-3 supplements. Screening or measuring omega-3 levels before 20 weeks of pregnancy will identify women who require omega-3 supplements. This project is evaluating how well an omega-3 screening program will work to reduce premature birth for women expecting one baby. There is not yet a screening test for women expecting twins or triplets.

Blood collection

After discussing with you, your health professional will order your omega-3 screening test on the SA Maternal Serum Antenatal Screening (SAMSAS) request form. Your omega-3 level will be measured using the blood already collected for the SAMSAS program. The test is provided free to families.

Information for families

Get in touch

We acknowledge funding support from the below organisations